Table 2.
Preoperative characteristics of men at NCCN very low risk with insignificant tumors and those reclassified with significant tumors
| White |
AA |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Insignificant | Significant | p Value | Insignificant | Significant | p Value | |||||
| No. pts (%) | 63 | (70.8) | 26 | (29.2) | <0.001* | 34 | (39.1) | 53 | (60.9) | <0.001* |
| Mean age | 56.6 | 58.8 | 0.949 | 57.1 | 59.0 | 0.338 | ||||
| Median ng/ml PSA (IQR) | 4.4 | (3.4, 5.7) | 4.4 | (3.0, 5.0) | 0.459 (Wilcoxon-Mann-Whitney test)* | 4.4 | (3.0, 6.0) | 4.7 | (3.7, 5.7) | 0.617 (Wilcoxon-Mann-Whitney test) |
| Median gm prostate size (IQR) | 49.9 | (35.2, 57.0) | 44.4 | (30.6, 53.4) | 0.194 (Wilcoxon-Mann-Whitney test) | 46.0 | (36.2, 63.0) | 48.0 | (27.8, 56.0) | 0.070 (Wilcoxon-Mann-Whitney test) |
| Median ng/ml/gm PSAD (IQR) | 0.09 | (0.06, 0.12) | 0.08 | (0.07, 0.10) | 0.773 (Wilcoxon-Mann-Whitney test) | 0.07 | (0.06, 0.10) | 0.09 | (0.08, 0.12) | 0.003 (Wilcoxon-Mann-Whitney test) |
| No. pos cores (%): | 0.009 | 0.021 | ||||||||
| 1 | 43 | (68.3) | 10 | (38.5) | 24 | (70.6) | 24 | (45.3) | ||
| 2 | 20 | (31.7) | 16 | (61.5) | 10 | (29.4) | 29 | (54.7) | ||
| Median % Ca/core (IQR) | 10.0 | (5.0, 25.0) | 10.0 | (5.0, 30.0) | 0.685 (Wilcoxon-Mann-Whitney test) | 10.0 | (5.0, 30.0) | 20.0 | (5.0, 30.0) | 0.137 (Wilcoxon-Mann-Whitney test) |
| No. CAPRA (%): | 0.065 | 0.760 | ||||||||
| 0–1 | 51 | (81.0) | 25 | (96.2) | 26 | (76.5) | 42 | (79.2) | ||
| 2–3 | 12 | (19.0) | 1 | (3.8) | 8 | (23.5) | 11 | (20.8) | ||
| No. family history (%) | 28 | (44.4) | 13 | (50.0) | 0.633 | 16 | (47.1) | 20 | (37.7) | 0.389 |
| Median kg/m2 BMI (IQR) | 27.2 | (24.8, 29.7) | 27.3 | (25.1, 29.0) | 0.948 (Wilcoxon-Mann-Whitney test) | 28.2 | (26.1, 30.3) | 27.3 | (25.8, 30.1) | 0.314 (Wilcoxon-Mann-Whitney test) |
*
White men with significant tumors vs AA men with significant tumors.